Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791945 · ClinicalTrials.gov registry record · Phase 2
N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT02791945: Completed Phase 2 study, sponsored by University of California, San Francisco.
NCT02791945 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02791945, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of the project is to improve the care of Veterans with mild traumatic brain injury (mTBI) and unhealthy alcohol use.
Primary Outcome
The TLFB interview, using a calendar, asks participants to report the prior week's frequency of alcohol use on each day of the week.
Interventions
- DRUG Placebo
- DRUG N-acetylcysteine
- BEHAVIORAL Medical Management Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-05 |
| Phase | Phase 2 |
What the finished NCT02791945 record still lists
NCT02791945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02791945 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02791945 about?
NCT02791945 is a clinical study titled "N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI". The goal of the project is to improve the care of Veterans with mild traumatic brain injury (mTBI) and unhealthy alcohol use.
What is the current status of trial NCT02791945?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2016-08. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02791945?
The interventions under investigation include: Placebo (DRUG), N-acetylcysteine (DRUG), Medical Management Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02791945?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02791945's enrollment target sits among peer trials
30 1582nd of 2000 higher than 332 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia